Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Brinzolamide
Drug ID BADD_D00296
Description Brinzolamide is a highly specific, non-competitive, reversible carbonic anhydrase inhibitor. Carbonic anhydrase (CA) is an enzyme found in many tissues of the body including the eye. It catalyzes the reversible reaction involving the hydration of carbon dioxide and the dehydration of carbonic acid. In humans, carbonic anhydrase exists as a number of isoenzymes, the most active being carbonic anhydrase II (CA-II). Inhibition of carbonic anhydrase in the ciliary processes of the eye decreases aqueous humor secretion, presumably by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport. The result is a reduction in intraocular pressure. Brinzolamide is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Indications and Usage For the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Marketing Status approved
ATC Code S01EC04
DrugBank ID DB01194
KEGG ID D00652
MeSH ID C111827
PubChem ID 68844
TTD Drug ID D01MUR
NDC Product Code 40700-0072; 55718-165; 0078-0722; 14445-010; 65727-033; 68682-464; 58032-2011; 62009-0906; 63190-0280; 68108-0821; 58567-101; 82019-0001; 0591-2127; 0781-6014; 62207-011; 24208-464; 63629-8793; 63190-0400
UNII 9451Z89515
Synonyms brinzolamide | (R)-4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-E)-1,2-thiazine-6-sulfonamide 1,1-dioxide | Azopt
Chemical Information
Molecular Formula C12H21N3O5S3
CAS Registry Number 138890-62-7
SMILES CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Renal impairment20.01.03.0100.001871%Not Available
Bronchial hyperreactivity22.03.01.016--Not Available
Treatment failure08.06.01.0170.037369%Not Available
Oropharyngeal pain22.12.03.016; 07.05.05.0040.001263%
Upper-airway cough syndrome22.12.03.036--
Depersonalisation/derealisation disorder19.14.01.004--Not Available
Concomitant disease aggravated08.01.03.0630.000702%Not Available
Eye paraesthesia17.02.06.041; 06.01.01.0100.000468%Not Available
Eyelid myoclonus17.12.03.034; 06.05.01.0050.000468%Not Available
Product residue present13.15.01.049--Not Available
The 8th Page    First    Pre   8    Total 8 Pages